Perseus Proteomics (TSE:4882) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics Days Payable?

Perseus Proteomics's average Accounts Payable for the three months ended in Dec. 2023 was 円0.00 Mil. Perseus Proteomics's Cost of Goods Sold for the three months ended in Dec. 2023 was 円1.14 Mil. Hence, Perseus Proteomics's Days Payable for the three months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Perseus Proteomics's Days Payable or its related term are showing as below:

TSE:4882's Days Payable is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 88.97
* Ranked among companies with meaningful Days Payable only.

Perseus Proteomics's Days Payable stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00). stayed the same

Perseus Proteomics Days Payable Historical Data

The historical data trend for Perseus Proteomics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics Days Payable Chart

Perseus Proteomics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Payable

Get a 7-Day Free Trial

Perseus Proteomics Quarterly Data
	Mar18	Mar19	Dec19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Perseus Proteomics's Days Payable

For the Drug Manufacturers - General subindustry, Perseus Proteomics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Perseus Proteomics's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perseus Proteomics's Days Payable distribution charts can be found below:

* The bar in red indicates where Perseus Proteomics's Days Payable falls into.

Perseus Proteomics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Perseus Proteomics's Days Payable for the fiscal year that ended in Mar. 2023 is calculated as

	Days Payable (A: Mar. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2022 )	+	Accounts Payable (A: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	7.669	*	365
=	0					/	7.669	*	365
=	0.00

Perseus Proteomics's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	1.136	*	365 / 4
=	0					/	1.136	*	365 / 4
=	0.00

Perseus Proteomics Days Payable Related Terms

Thank you for viewing the detailed overview of Perseus Proteomics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Perseus Proteomics (TSE:4882) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041

Website

https://www.ppmx.com

Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics (TSE:4882) Headlines

No Headlines